Trials / Sponsors / Embera NeuroTherapeutics, Inc.
Embera NeuroTherapeutics, Inc.
Industry · 6 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | Study of EMB-001 as a Potential Smoking Cessation Treatment Tobacco Use Disorder | Phase 1 / Phase 2 | 2021-06-10 |
| Completed | A Study to Evaluate EMB 001 in Subjects With Cocaine Use Disorder Cocaine Use Disorder | Phase 2 | 2020-07-29 |
| Completed | Single Dose Crossover Comparative Bioavailability and Food Effect Study of Two EMB-001 Formulations Cocaine Use Disorder | Phase 1 | 2018-03-01 |
| Completed | A Study of Metyrapone and Oxazepam Combination Product (EMB-001) and Cocaine Cocaine Use Disorder | Phase 1 | 2016-07-01 |
| Completed | Single and Multiple Rising Dose Study of Safety and PK of Metyrapone/Oxazepam Combination (EMB-001) Cocaine Use Disorder, Tobacco Use Disorder | Phase 1 | 2015-03-01 |
| Completed | A Placebo-Controlled Study of a Combination of Metyrapone and Oxazepam in Cocaine Addiction Cocaine Dependence, Cocaine Addiction | N/A | 2007-12-01 |